Tefferi et al. studied 254 PMF patients and concluded that patients with CALR mutations were younger, with a higher platelet count, and presented with lower DIPSS-plus score; additionally, they were also less likely to require blood transfusions for anemia or present with leukocytosis [76]. The gene discussed is CALR; the disease is anemia.